Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
219 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3138 (93%)
3367
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
341 (93%)
Reversed:
0 (0%)
365
144 (4%)
68 (28%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-30 | 2021-06-07 | 138340 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-17 | 2021-10-12 | 145831 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-07 | 2022-01-24 | 152301 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-14 | 2022-02-18 | 152761 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-14 | 2022-02-18 | 152764 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-03 | 2019-01-17 | 71118 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-21 | 2019-04-05 | 76582 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-10 | 2019-05-14 | 80926 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-30 | 2019-05-13 | 82837 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-21 | 2019-09-16 | 92019 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156987 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-25 | 2022-04-01 | 157298 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2020-10-08 | 124344 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-03-27 | 2018-07-03 | 44102 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-16 | 2018-10-02 | 55836 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-23 | 2024-03-29 | 220465 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-16 | 2023-04-06 | 187238 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-29 | 190874 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-06 | 2023-05-12 | 191898 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-26 | 2023-07-21 | 193218 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |